company background image
603883 logo

LBX Pharmacy Chain SHSE:603883 Stock Report

Last Price

CN¥18.11

Market Cap

CN¥13.8b

7D

-1.7%

1Y

-19.9%

Updated

21 Nov, 2024

Data

Company Financials +

LBX Pharmacy Chain Joint Stock Company

SHSE:603883 Stock Report

Market Cap: CN¥13.8b

LBX Pharmacy Chain Joint Stock Company Competitors

Price History & Performance

Summary of all time highs, changes and price drops for LBX Pharmacy Chain
Historical stock prices
Current Share PriceCN¥18.11
52 Week HighCN¥28.38
52 Week LowCN¥11.90
Beta0.43
11 Month Change8.57%
3 Month Change47.00%
1 Year Change-19.89%
33 Year Change-31.96%
5 Year Change-41.30%
Change since IPO81.33%

Recent News & Updates

We Think You Can Look Beyond LBX Pharmacy Chain's (SHSE:603883) Lackluster Earnings

Nov 06
We Think You Can Look Beyond LBX Pharmacy Chain's (SHSE:603883) Lackluster Earnings

Recent updates

We Think You Can Look Beyond LBX Pharmacy Chain's (SHSE:603883) Lackluster Earnings

Nov 06
We Think You Can Look Beyond LBX Pharmacy Chain's (SHSE:603883) Lackluster Earnings

LBX Pharmacy Chain Joint Stock Company's (SHSE:603883) Price Is Right But Growth Is Lacking After Shares Rocket 30%

Sep 06
LBX Pharmacy Chain Joint Stock Company's (SHSE:603883) Price Is Right But Growth Is Lacking After Shares Rocket 30%

Is LBX Pharmacy Chain (SHSE:603883) Using Too Much Debt?

Sep 02
Is LBX Pharmacy Chain (SHSE:603883) Using Too Much Debt?

Take Care Before Jumping Onto LBX Pharmacy Chain Joint Stock Company (SHSE:603883) Even Though It's 30% Cheaper

Jul 03
Take Care Before Jumping Onto LBX Pharmacy Chain Joint Stock Company (SHSE:603883) Even Though It's 30% Cheaper

Here's Why We Think LBX Pharmacy Chain (SHSE:603883) Is Well Worth Watching

Jun 08
Here's Why We Think LBX Pharmacy Chain (SHSE:603883) Is Well Worth Watching

LBX Pharmacy Chain (SHSE:603883) Seems To Use Debt Quite Sensibly

May 21
LBX Pharmacy Chain (SHSE:603883) Seems To Use Debt Quite Sensibly

There Is A Reason LBX Pharmacy Chain Joint Stock Company's (SHSE:603883) Price Is Undemanding

Apr 22
There Is A Reason LBX Pharmacy Chain Joint Stock Company's (SHSE:603883) Price Is Undemanding

Shareholder Returns

603883CN Consumer RetailingCN Market
7D-1.7%-3.9%-3.4%
1Y-19.9%-10.3%6.1%

Return vs Industry: 603883 underperformed the CN Consumer Retailing industry which returned -10.3% over the past year.

Return vs Market: 603883 underperformed the CN Market which returned 6.1% over the past year.

Price Volatility

Is 603883's price volatile compared to industry and market?
603883 volatility
603883 Average Weekly Movement13.0%
Consumer Retailing Industry Average Movement7.9%
Market Average Movement8.2%
10% most volatile stocks in CN Market12.6%
10% least volatile stocks in CN Market5.5%

Stable Share Price: 603883's share price has been volatile over the past 3 months compared to the CN market.

Volatility Over Time: 603883's weekly volatility has increased from 8% to 13% over the past year.

About the Company

FoundedEmployeesCEOWebsite
200140,881Li Wangwww.lbxdrugs.com

LBX Pharmacy Chain Joint Stock Company operates pharmacy store chain in China. The company was formerly known as Laobaixing Pharmacy Chain Joint Stock Company. LBX Pharmacy Chain Joint Stock Company was founded in 2001 and is based in Changsha, China.

LBX Pharmacy Chain Joint Stock Company Fundamentals Summary

How do LBX Pharmacy Chain's earnings and revenue compare to its market cap?
603883 fundamental statistics
Market capCN¥13.77b
Earnings (TTM)CN¥842.61m
Revenue (TTM)CN¥22.63b

16.3x

P/E Ratio

0.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
603883 income statement (TTM)
RevenueCN¥22.63b
Cost of RevenueCN¥15.06b
Gross ProfitCN¥7.56b
Other ExpensesCN¥6.72b
EarningsCN¥842.61m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)1.11
Gross Margin33.42%
Net Profit Margin3.72%
Debt/Equity Ratio53.4%

How did 603883 perform over the long term?

See historical performance and comparison

Dividends

3.7%

Current Dividend Yield

75%

Payout Ratio